Referencias Bibliográficas sobre Probióticos Intestinales

(1)Murzyn et al., (2010), ‘Capric Acid Secreted by S. boulardii Inhibits C. Albicans’. Plos One, 5(8).

(2)Majeed, M., Nagabhushanam, K., Natarajan, S. et al. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study. Nutr J 15, 21 (2015). https://doi.org/10.1186/s12937-016-0140-6

(3)Dolin BJ. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol. 2009 Dec;31(10):655–9.

(4)Rogha M, Esfahani MZ, Zargarzadeh AH. The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Gastroenterol Hepatol Bed Bench. 2014;7(3):156–63.

(5)Alm L, Ryd-Kjellen E, Setterberg G, Blomquist L (1993). Effect of a new fermented milk product ‘CULTURA’ on constipation in geriatric patients. 1st Lactic Acid Bacteria Computer Conference Proceedings. Horizon Scientific Press: Norfolk, England

(6)Fox MJ, Ahuja KDK, Robertson IK, et al Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study BMJ Open 2015;5:e006474. doi: 10.1136/bmjopen-2014-006474

(7)Lillian Jespersen, Inge Tarnow, Dorte Eskesen, Cathrine Melsaether Morberg, Birgit Michelsen, Susanne Bügel, Lars Ove Dragsted, Ger T Rijkers, Philip C Calder, Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study, The American Journal of Clinical Nutrition, Volume 101, Issue 6, June 2015, Pages 1188–1196, https://doi.org/10.3945/ajcn.114.103531

(8)Mogna L, Del Piano M, Deidda F, et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012;46 Suppl:S29-S32. doi:10.1097/MCG.0b013e31826852b7

(9)Mohedano ML, Hernández-Recio S, Yépez A, Requena T, Martínez-Cuesta MC, Peláez C, Russo P, LeBlanc JG, Spano G, Aznar R and López P (2019) Real-Time Detection of Riboflavin Production by Lactobacillus plantarum Strains and Tracking of Their Gastrointestinal Survival and Functionality in vitro and in vivo Using mCherry Labeling. Front. Microbiol. 10:1748. doi: 10.3389/fmicb.2019.01748

(10)Huang Y, Wang X, Wang J, et al. Lactobacillus plantarum strains as potential probiotic cultures with cholesterol-lowering activity. J Dairy Sci. 2013;96(5):2746-2753. doi:10.3168/jds.2012-6123

(11)Del Piano M, Carmagnola S, Anderloni A, et al. The use of probiotics in healthy volunteers with evacuation disorders and hard stools: a double-blind, randomized, placebo-controlled study. J Clin Gastroenterol. 2010;44 Suppl 1:S30-S34. doi:10.1097/MCG.0b013e3181ee31c3

(12)S., Latvala & S., Philipp & M.J., Lehtinen & Lehtoranta, Liisa & A.C., Ouwehand. (2019). Health Benefits of a Combination Probiotics; FlorMidabil™. International Journal of Probiotics and Prebiotics. 14. 9-17. 10.37290/ijpp2641-7197.14:9-17.

(13)Sharma, Rohit & Bhaskar, Bhuwan & Sanodiya, Bhagwan Singh & Thakur, Gulab & Jaiswal, Pallavi & Yadav, Nitin & Sharma, Anjana & Bisen, Prakash. (2014). Probiotic Efficacy and Potential of Streptococcus thermophilus modulating human health: A synoptic review. IOSR Journal of Pharmacy and Biological Sciences. 9. 2319-7676. 10.9790/3008-09325258.

(14)Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus  rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015 Nov;42(10):1149-57.

(15)Segers ME, Lebeer S. Towards a better understanding of Lactobacillus rhamnosus GG–host interactions. Microb Cell Fact. 2014 Aug 29;13 Suppl 1:S7.

(16)Rao R, Samak G. Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions. J Epithel Biol Pharmacol. 2012;5(Suppl 1-M7):47-54. doi:10.2174/1875044301205010047

(17)Verdenelli MC, Silvi S, Cecchini C, Orpianesi C, Cresci A. Influence of a combination of two potential probiotic strains, Lactobacillus rhamnosus IMC 501® and Lactobacillus paracasei IMC 502® on bowel habits of healthy adults. Lett Appl Microbiol. 2011;52(6):596-602. doi:10.1111/j.1472-765X.2011.03042.x

(18)Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr. 2001;20(2 Suppl):149-156. doi:10.1080/07315724.2001.10719027

(19)Zamfir M, Callewaert R, Cornea PC, De Vuyst L. Production kinetics of acidophilin 801, a bacteriocin produced by Lactobacillus acidophilus IBB 801. FEMS Microbiol Lett. 2000;190(2):305-308. doi:10.1111/j.1574-6968.2000.tb09303.x

(20)Pakdaman MN, Udani JK, Molina JP, Shahani M. The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance – a randomized, double-blind, placebo-controlled, crossover clinical trial. Nutr J. 2016;15(1):56. Published 2016 May 20. doi:10.1186/s12937-016-0172-y

(21)Nagala, R. and c. Routray. 2011. “Clinical Case Study-Multispecies Probiiotic Supplement Minimizes Sysmtoms of Irritable bowel Syndrome.” US Gastroenterology & Hepatology Review

(22)Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in Human Health and Diseases. Front Microbiol. 2018;9:757. Published 2018 Apr 19. doi:10.3389/fmicb.2018.00757

(23)Toscano, M., De Grandi, R., Miniello, V. L., Mattina, R., & Drago, L. (2017). Ability of Lactobacillus kefiri LKF01 (DSM32079) to colonize the intestinal environment and modify the gut microbiota composition of healthy individuals. Digestive and Liver Disease49(3), 261-267. https://doi.org/10.1016/j.dld.2016.11.011

(24)Pugh JN et al 2019. Four weeks of probiotic supplementation reduces GI symptoms during a marathon race.
European Journal of Applied Physiology

(25)Roberts JD et al 2016. An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention. Nutrients 8:733.

(26)Garaiova I et al 2015. Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study. European Journal of Clinical Nutrition 69: 373-379

(27)Williams EA et al 2008. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Alimentary Pharmacology & Therapeutics, 29: 97-103

(28)Ouwehand AC, DongLian C, Weijian X, et al. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine. 2014;32(4):458-463. doi:10.1016/j.vaccine.2013.11.053

(29) Steven M Faber. September, 2000. Treatment of abnormal gut flora improves symptoms in patients with irritable bowel syndrome Elizabeth City, N.C., United States. A.Journal of Gastroenterology, 95(9):2533. 

(30)Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, Simoneau G, Bergmann JF, Brassart D, Bornet F, Ouwehand AC. 2008. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol. 53: 107-13.

(31)Ouewhand et al, (2009) ‘Specific probiotics alleviate allergic rhinitis during the birch pollen season’, World Journal of Gastronenterology, 15: 3261-3268.

(32)C.B. Wong, T. Odamaki, J. XiaoBeneficial effects of Bifidobacterium longum subsp. longum BB536 on human health: modulation of gut microbiome as the principal action

J Funct Foods, 54 (2019), pp. 506-519

(33)Actor JK, Hwang SA, Kruzel ML. Lactoferrin as a natural immune modulator. Curr Pharm Des. 2009;15(17):1956-1973. doi:10.2174/138161209788453202

(34) Lorenzo-Zúñiga V, Llop E, Suárez C, et al. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol. 2014;20(26):8709-8716. doi:10.3748/wjg.v20.i26.8709

(35) Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;(11):CD003048.

(36) Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015 Oct;42(7):793–801.

(37) Goldenberg JZ, Ma SSY, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.

(38)Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, et al. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):531–9.

(39)Palaniyandi SA, Damodharan K, Suh JW, Yang SH. Probiotic Characterization of Cholesterol-Lowering Lactobacillus fermentum MJM60397 [published online ahead of print, 2019 Aug 20]. Probiotics Antimicrob Proteins. 2019;10.1007/s12602-019-09585-y. doi:10.1007/s12602-019-09585-y